Having begun his scientific career within the diagnostic environment of the Pathology Department of Leicester Royal Infirmary Andrew subsequently joined Huntingdon Life Science as Head of Specialised Histological Techniques and introduced and developed a range of specialised histology technologies including Immunohistochemistry, in particular human tissue cross-reactivity testing. Before setting up HistologiX Ltd Andrew worked at Source Bioscience where he was involved with the development of cell signalling biomarkers. Andrew is currently responsible for all immunohistochemistry and hisology based projects and has a wealth of knowledge of screening many different types of antibody and non-antibody based molecules.
Elaine is the IHC Manager at HistologiX and is responsible for the management and coordination of the Immunohistochemistry Laboratories.
Elaine began her scientific career in the Histopathology department of Queen’s Medical Centre sectioning breast and colon cancer tissues and performing IHC & radioactive-ISH assays. Elaine moved to a research group within the University of Leicester whose focus was IgA nephropathy. During that time she gained experience in a wide range of techniques, and was responsible for the management of expenditure for the grant accounts and Health and Safety. At Medical Solutions plc (Source BioScience), Elaine took a change of direction moving working as part of the drug discovery team where she helped set up GLP procedures within the laboratory.
In 2006 she joined HistologiX, initially as a member of the histology and IHC teams and then progressing to IHC Manager. With her extensive practical experience of Immunohistochemistry techniques, she is well placed to support clients from project proposal to completion.
Susan is the Histology Manager at HistologiX and is responsible for the management and coordination of the Histology Laboratories. She has expert knowledge of frozen sectioning, tissue processing/embedding, microtomy, routine H&E stain, special staining, immunohistochemistry, immunofluorescence and in-situ hybridization procedures.
Having begun her scientific career within the Pharmaceutical environment of the Histology Department at Boots Pharmaceuticals, Susan subsequently joined Astra, which later became AstraZeneca, as a Histology Technician where she performed histology techniques, special staining and ImmunoHistoChemistry (IHC) techniques. Susan had a brief career change and worked as a Microbiologist for a Manufacturing Company for several years before returning to the Pharmaceutical Industry. Throughout her career Susan has been Health and Safety Representative for the departments that she has worked in and has gained IOSH accreditation. At HistologiX, Susan prepares COSHH & Risk Assessments, ensuring compliance with Health and Safety regulations.
Amanda is the Office & Accounts Manager at HistologiX Ltd, responsible for Procurement, HR and Finance. She supports studies from inception through protocol design, implementation, and the final presentation of results. Amanda also manages the Quality Management system, and as named Archivist ensures compliance of legal and regulatory requirements for client projects.
Amanda has over 24 years’ experience within Office Administration, team supervision, Finance & HR. Starting her career in the Care Industry, she quickly advanced to became a Registered Care home Manager. She has also worked for the UK’s largest Energy Providers within their Learning & Development Team, gaining a Diploma in First Line Management. Amanda has been at HistologiX since 2015.
Sunita joined HistologiX in November 2015 as the Business Development Manager.
Within the NHS, Sunita qualified as a Biomedical Scientist in Histology and worked in various histopathology laboratories. Following this, Sunita completed a Masters in Research and then gained experience in Molecular Pathology (Oncology) within Large Pharma. As a Research Scientist, she worked on IHC, FISH, method development, digital image analysis and study reporting within the preclinical and clinical drug development setting. Sunita worked in commercial and training roles for one of largest global providers of digital pathology, before joining HistologiX. With her sales and scientific background, she is well placed to devise project proposals through scientific discussion, and strengthen the relationship with clients.
Histologix provides the Pharmaceutical and Biotechnology industry with specialist pathology services to assist drug development programmes ranging from Discovery, regulatory preclinical safety testing through to clinical trials and include human tissue sourcing, histology, medical and veterinary histopathology, immunohistochemistry, digital pathology and image analysis. These are technologies that have been developed with to meet current and future requirements of targeted therapy.
Through inward investment the services provided by Histologix Ltd use a range of highly sophisticated technologies and platforms aimed at standardising the various processes involved in order to achieve data generation that is consistent, accurate and reproducible and will assist our clients in the development of their drug programmes.
Histologix is a privately owned contract research organisation that provides specialist pathology services for the Pharmaceutical and Biotechnology industry. Set up in 2005 by industry specialists, Histologix is a GLP/GCP accredited, HTA-licenced company with an extensive and impressive track record of successfully delivering a range of IHC/ISH assays to large and small Pharma/Biotechnology companies and is a preferred supplier of these services to a number of companies.
Find out which conference Histologix is exhibiting at, updated news issues and current vacancies.